Ostrowska A, Bode D C, Pruss J, Bilir B, Smith G D, Zeisloft S
International Institute for the Advancement of Medicine, Scranton, PA, USA; IIAM/T3, 125 May St., Suite 300, Edison, N7 08837, USA (Tel.: (732) 661-2367; E-mail:
Cell Tissue Bank. 2000;1(1):55-68. doi: 10.1023/A:1010175906791.
There is a pressing need for alternative therapeutic methods effective in the treatment of patients with liver insufficiency. Isolated human hepatocytes may be a viable alternative or adjunct to orthotopic liver transplantation in such patients. The purpose of this study was to evaluate the viability and functional integrity of freshly isolated and cryopreserved human hepatocytes, in preparation for a multi-center human hepatocyte transplantation trial. We are currently processing transplant-grade human parenchymal liver cells from nondiseased human livers that are obtained through a network of organ procurement organizations (OPOs). Thus far, sixteen hepatocyte transplants have been performed using hepatocytes processed by our methods. At the time of referral all specimens were deemed unsuitable for transplantation due to anatomical anomalies, high fat content, medical history, etc. Hepatocytes were isolated from encapsulated liver sections by a modified two-step perfusion technique. Isolated cells were cryopreserved and stored in liquid nitrogen for one to twelve months. The total yield of freshly isolated hepatocytes averaged 3.7x10(7) cells per gram of wet tissue. Based on trypan blue exclusion, fresh preparations contained an average of 85% viable hepatocytes vs. 70% in cryopreserved samples. The plating efficiencies of cells seeded immediately after isolation ranged from 87% to 98%, while those of cryopreserved/thawed cells were markedly lower. Flow cytometry analysis of cells labeled with 5,6-carboxyfluorescein diacetate succinimidyl ester (CFSE) showed that there was no significant difference in viability compared with trypan blue staining. Both freshly isolated hepatocytes and those recovered from cryopreservation showed typical and intact morphology as demonstrated by light and electron microscopy. The product of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) reaction was always expressed more intensely in cultures of freshly isolated hepatocytes. Measurements of lactate dehydrogenase (LDH) leakage were inversely correlated with trypan blue exclusion and CFSE labeling. Energy status, evaluated by the intracellular ATP concentration measurements, and various liver-specific functions such as urea synthesis and metabolism of 7-ethoxycoumarin were maintained both in fresh and cryopreserved/thawed hepatocytes. However, the activities were expressed at different levels in thawed cells. These data illustrate the importance and feasibility of human hepatocyte banking. In addition, it is clear that further refinements in the methods of hepatocyte isolation and cryopreservation are needed to utilize more fully these valuable cells in the clinic.
迫切需要有效的替代治疗方法来治疗肝功能不全患者。对于这类患者,分离的人肝细胞可能是原位肝移植的一种可行替代方法或辅助手段。本研究的目的是评估新鲜分离和冷冻保存的人肝细胞的活力和功能完整性,为多中心人肝细胞移植试验做准备。我们目前正在处理从通过器官采购组织(OPO)网络获得的健康人肝脏中获取的移植级人肝实质细胞。到目前为止,已经使用我们方法处理的肝细胞进行了16例肝细胞移植。在转诊时,由于解剖异常、高脂肪含量、病史等原因,所有标本都被认为不适合移植。通过改良的两步灌注技术从包被的肝切片中分离肝细胞。分离的细胞被冷冻保存并在液氮中储存1至12个月。新鲜分离的肝细胞每克湿组织的总产量平均为3.7×10⁷个细胞。基于台盼蓝排斥试验,新鲜制剂中平均有85%的活肝细胞,而冷冻保存样本中为70%。分离后立即接种的细胞的接种效率在87%至98%之间,而冷冻保存/解冻细胞的接种效率明显较低。用5,6-羧基荧光素二乙酸琥珀酰亚胺酯(CFSE)标记的细胞的流式细胞术分析表明,与台盼蓝染色相比,活力没有显著差异。新鲜分离的肝细胞和从冷冻保存中复苏的肝细胞在光镜和电镜下均显示出典型且完整的形态。在新鲜分离的肝细胞培养物中,3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)反应产物的表达始终更为强烈。乳酸脱氢酶(LDH)泄漏的测量与台盼蓝排斥试验和CFSE标记呈负相关。通过细胞内ATP浓度测量评估的能量状态以及各种肝脏特异性功能,如尿素合成和7-乙氧基香豆素的代谢,在新鲜和冷冻保存/解冻的肝细胞中均得以维持。然而,解冻细胞中的活性表达水平不同。这些数据说明了人肝细胞库的重要性和可行性。此外,很明显,需要进一步改进肝细胞分离和冷冻保存方法,以便在临床上更充分地利用这些有价值的细胞。